Dr Munshi speaks with ecancer at EBMCI 2017 about how early detection and increased specificity have opened treatment options for patients with early lung cancer.

He describes how a hypofractionation schedule can accelerate treatment and recovery, matching or exceeding the outcomes achievable with surgery.

This topic was part of a debate session at the conference, with the opposing view discussed by Dr Arvind Kumar here.